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Any input to support the criticald ailyc hoice of whichc ompound to synthesize, test, and promote is of utmost importance to identify those compounds with the highest probability of overcoming all obstacles in drugd iscovery and development, and to ultimately become am arketed medicine for the patient'sb enefit. Apart from efficacya nd toxicity,m any failures during drug development are related to pharmacokinetics, i.e., the fate of the compound in the organism. [1] Nowadays,b y monitoring physicochemical profiles of lead compounds it is possible to increase the quality of clinical candidates. [2] The individual consideration of absorption, distribution, metabolism and excretion (ADME) behaviors at the early stages of drug discovery has decreased the fraction of globalp harmacokineticsrelated failures in later phases of development. As ac onsequence, today,d rug candidates reach the market more efficiently. [3] Althought here are different routes of drug administration, oral dosingi sh ighly preferred for the patient'sc omfort and compliance. Early estimation of oral bioavailability,i.e.,the fraction of the dose that reaches the bloodstream after oral administration, is ak ey decision-making criterion atv arious steps of the discovery process. Bioavailability is highly multifactorial, but is primarily driven by gastrointestinal absorption. [4] The large number of moleculesa nd the small physical sample amounta ti nitial stage of medicinal chemistry projects, togetherwith the need to limit animal testing, prevent systematic recourse to experiments. This has fosteredc omputational models that are able to predict pharmacokinetic parameters, especially bioavailability. [5] The eminent rule-of-five by Lipinski and co-workersp rovides physicochemical margins outside of which the probability for am olecule to become an oral drug is low. [6] Despite criticism, often due to over-interpretation, the rule-of-five shed light on the relationship between bioavailability and physicochemical properties, settling the concept of drug-likeness, and inspired many simple rule-based models. Later,m ore sophisticated and precise modelsb ased on machine-learning methods were built. However,t hese latter share the severe drawback of being "black boxes" difficult to interpret and to translate into molecular design. [7] An elegant compromise between these two types of models was proposed by Egan et al., [8] who developed ad escriptive representation to discriminate between well-absorbed and poorly absorbed molecules based on their lipophilicity and polarity,d escribed by the n-octanol/water partition coefficient (log P)a nd the polar surface area (PSA). The delineation exists in ar egion of favorable properties for gastrointestinal absorption on ap lot of two computed descriptors:A LOGP98 [9] versus PSA. [10] Because the region most populatedb yw ell-absorbed molecules is elliptical, it was called the Egan egg.T he advantages of this representation are related to its simple concept, straightforward interpretation, andd irect translation into molecular design (unlike machine-learning methods). In contrast to rule-based modelsa nd thanks to its 2D graphical nature, it not only provides thresholds, but also ac lear picture of how far am olecular structure is from the ideal physicochemical regionf or good absorption. As lipophilicity and polarity are often inverselyc orrelated properties, the sometimes-tricky chemicalm odifications simultaneouslyi mpacting log P and PSA are efficientlys upported by the model, which is rapid enough to allow trial-and-error iterations. These practical benefits make the Egane gg widely used in industriala nd academic contexts, as indicated by its implementation in commercial packages (e.g.,D iscovery Studio, Dassault Systmes BIOVIA, San Diego, CA, USA) and numerous citationso ft he seminala rticles. [8, 11] Successful applicationsi nclude, for example, the discoverya nd development of the groundbreaking drug against hepatitis C, telaprevir, [12] and ad etailedp harmacokinetic analysis leadingt oa nti-tuberculosis agents. [13] [a] A. Daina However,E gan'sm ethod comes with some concerns. Althoughroutinelya pplied as aprediction tool, it was developed as ad elineation, merely descriptive andw ithout evaluation of predictivep ower.I ndeed, the computation of the ellipse took into account well-absorbed molecules but neglected poorly absorbed molecules. The resulting confidence region merely depictsthe dispersion of properties relatedtog ood absorption and lacks an assessment of accuracy.A dditionally,s everal points hindert he reproducibility of the published methodology:t he dataset was not fully disclosed; the values of ALOGP98 [9] were obtained throughaclosed-source commercial implementation;a nd the detailso fP SA calculations relyingo n tridimensional geometries were not described.
Given the undeniable practicality of Egan'se gg and its effectivenessf or drug discovery projects, we sought to amend these methodological aspects, to assess the predictive power of the model for gastrointestinalp assivea bsorption, and to complementi tw ith the prediction forb rain access by passive diffusion to finally lay the BOILED-Egg (Brain Or IntestinaL EstimateD permeation predictivemodel).
We curated recent humani ntestinala bsorption (HIA) data [4] by literature, patent,a nd database cross-checks (refer to Methods S1 in the Supporting Information) to gather 660 small molecules (567 well-and 93 poorly absorbed) with cleansed structures and reliable measurements of the fractiona bsorbed by human (FA), excluding actively transported compounds. This HIA dataseti sg iven in Table S1 in the Supporting Information. All 660 molecular structures were subjectt ol og P and PSA computation (Figure 1 ; see Methods S3 in the Supporting Information for details). The log P method developed by Wildman and Crippen (WLOGP) was chosen,because it is closely related to ALOGP98, but with exhaustive chemical description, which makesi ts implementation straightforward. [14] Likewise, we calculated the topological polar surface area (tPSA), aw elldescribed technique to estimate PSA based on a2 Df ragmental system. [10] The ellipse that best classifies the 660 molecules of the HIA dataset was computed by including as many well-absorbed and as less poorly absorbedc ompounds as possible on the WLOGPv ersus tPSA plot (details in Methods S4, S5, and S6 in the Supporting Information). Five parameters defining the ellipse-the Cartesian coordinates of the foci (x 1 , x 2 ); (y 1 , y 2 )a nd the major axis (or largest diameter, d)-were submitted to Monte-Carlo (MC) optimization, evaluated by the Matthews correlation coefficient (MCC, ranging from À1t o1for perfect classification, see MethodsS7). After about1 00 000 independent MC runs of 100 000 cycles each, with starting parameters spanning the desired physicochemical space, the optimal ellipse was obtainedw ith an excellent MCC = 0.70 (Figure 1a and 1c,a nd Data S1 and Figure S1 in the Supporting Information). Reasons for misclassification can be attributed to either technical issues, i.e.,WLOGP or tPSA do not accurately describe the lipophilicity and polarity of particular compounds, or to conceptuali ssues,i .e.,o ther unrelated properties impact absorption. These latter properties, if linked to the molecular structure( e.g.,i ts charge), could eventually be considered by additional orthogonal axes. Physicochemical description issues could explain part of the 26 false positives (structures depicted in Figure S5 ), as many of these bear positive charges. In other cases, the neglected properties are most probablyp hysiological. Even ah igh-quality dataset is influenced by the state of knowledge at the time of curation. This can explain part of the 20 false negatives, as ag iven molecule could be considereda s absorbed passively just because itsa ctive transporter remains to be discovered [15] (structures depicted in Figure S6 ). Our passive absorption model, with an internal accuracy of 93 %, was furtherassessed by 10-fold cross-validation. The high cross-validated MCC, MCC CV = 0.65, and cross-validated accuracy of 92 %( see Methods S8 and Table S3 in the Supporting Information)t ogether with the fact that the ten ellipses show al arge overlap ( Figure S3 ) ascertainst he robustnesso fc lassification. Finally,o ur model confirms and refinest he guidelines for good absorption, [7] the ellipseb eing encompassed in the commonly accepted rectangularl imits of PSAl ower than 142 2 and log P between À2.3 and + 6.8. These resultse ncouraged us to extend the approach to blood-brain barrier (BBB) permeation, whichi sf undamental for the distribution of central-acting molecules, or reversely for limited unwanted effects of peripheral drugs. Similarly to bioavailability and given the substantial effort to measureB BB permeation, several computational methodsw ere developed. [16] Again, they can be divided in "Lipinski-like"r ule-based and in machine-learning models, but so far no "Egan-like" approachh as been published.
The BBB can be considered as as hield protecting the brain by a" physical" barrier (e.g.,t ight junctions in endothelial cells preventing paracellular penetration) and a" biochemical" barrier consisting of enzymatic activities and active efflux (e.g.,Pglycoprotein pumping out substrates from central nervous system (CNS) tissues). Although active transport is important, passived iffusion is the major route for drugs to access the brain from the bloodstream. [17] Substantial curation of ar ecent dataset [18] supported by specialized databases was required to build our passive BBB-permeation model (refer to Methods S2 in the Supporting Information). We collected 260 molecules (156 permeant and 104 non-permeant) with cleansed structures and reliable measurements of blood-brain partition (log BB). This BBB dataseti sp rovided in Table S2 . The same methodology as for the absorption classification was applied. Massively parallelized MC runs yielded the bestc lassifying ellipse on the WLOGPv ersust PSA graph for BBB permeation (MCC = 0.79, Figure 1b and 1d,a nd Data S2 andF igure S2 in the Supporting Information). Our model is in accordancew ith and refines the established simple guidelines giving PSA thresholds for BBB permeation. [16, 19] Indeed, we show that moderately polar (PSA < 79 2 )a nd relativelyl ipophilic (log P from + 0.4 to + 6.0) molecules have ah igh probability to access the CNS. Similarly to the gastrointestinal model, some of the 22 false positives can be attributed to the limitations of the WLOGPa nd tPSA descriptors ( Figure S7 in the Supporting Information). The imperfect currents tate of knowledge about active transport for discoveryo re arly development compounds could explain the fivef alse negatives ( Figure S8 ). However,w ith an internal classification accuracyo f9 0%,o ur BBB (Figure S4) . Figure 1 . Overview of the BOILED-Egg construction.a)Gastrointestinalabsorption and b) brain penetrationd atasets (HIA and BBB in Ta bles S1 and S2, respectively) cleansed,neutralized,s tandardized, converted into SMILES notationw ere subject to lipophilicity (WLOGP) and polarity (tPSA) computation. Best classification ellipse for well-and poorly absorbed molecules (blue points andgreen squares, respectively,i n(c) and Figure S1 ) as well as for brain penetranta nd non-penetrant molecules (pink points and brown squares, respectively,in( d) and FigureS2). e) Combining both best ellipses yields the BOILED-Egg predictive model. The white region is the physicochemical space of molecules with highest probability of being absorbed by the gastrointestinaltract, and the yellow region (yolk) is the physicochemical space of molecules with highest probability to permeate to the brain. Yolk and white areas are not mutually exclusive.
As an illustration, the 46 non-prodrug new chemicale ntities (NCEs) with clear oral bioavailability accepted by the FDA between January 2014 and September 2015( FDA dataseti n Ta ble S5)w ere mapped onto the BOILED-Egg (Figure 2a) . The vast majority of gastrointestinal absorption predictions are sensible, as indicated by ac lassification accuracyr eaching 83 %. The same appearst rue for BBB permeation, as most NCEs with evidencefor brain penetration lie inside the yellow ellipse.
In our practice, the BOILED-Egg is of great support for lead optimization. The following two cases illustrate how it can steer property-based lead optimization to improve pharmacokinetics. The first example is the optimization of third-generation BCR-ABL kinase inhibitors, startingf rom the lead BCR-ABL1w ith poor pharmacokinetics, distant from the egg, to finally obtain the oral anticancer drugp onatinib. [20] Ponatinib correctly lies inside the white ellipse, but inside the BOILED-Egg's yolk, too (blue path in Figures2ba nd S9). This agrees with experimental data suggesting that ponatinib crosses the BBB. [21] The second example is the optimization of AMPAr eceptor modulators to enhances ynaptic activity.T he optimization started from an orallyb ioavailable, but BBB non-permeant lead AMPA-1. The physicochemical modifications to finally obtain ab rain-penetrant investigational drug [22] correctly located in the yolk can be followed (pink path in Figures 2b and S10) .
The BOILED-Egg modeld elivers ar apid, intuitive, easily reproducible yet statistically unprecedented robustm ethod to predict the passive gastrointestinal absorption and brain access of smallm olecules useful for drug discovery and development. The BOILED-Egg is depicted in Figure 1c ,a nd the coordinates of respective ellipses are given in Figures S1 and S2 in the Supporting Information. Finally,a nE xcel file is provided as Data S3 (described in the Supporting Information), including the Cartesian coordinateso fb oth ellipses' trace. The user has the possibility to add the WLOGPand tPSA for up to 100 molecules, and the correspondingp oints are mapped onto the BOILED-Egg (detailed protocol in Methods S9).
